Verified· 2 sources

EvlaBio AG

Summary

About the company

The core activity of EvlaBio AG is the development of therapeutics, particularly first-in-class therapeutics in the field of cardiovascular and cardio-renal diseases. The focus is on the development of therapeutic monoclonal antibodies (mAb) that target specific target molecules such as FGFR4/FGF23 to treat chronic kidney diseases (CKD).

AI-generated

Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

EvlaBio AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

EvlaBio AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

EvlaBio AG in comparison

Industry comparisons are coming soon

Similar companies